IP Library Granted Patent US 8,932,579
Granted Patent B2
US 8,932,579 · App. 12/513,631 · Granted Jan 13, 2015

Biological effects of compositions comprising rosmarinic acid

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,932,579
App. No.
12/513,631
Granted
Jan 13, 2015
Kind
B2
Abstract

The present invention relates to compositions of rosmarinic acid or its derivatives and to the use of a hydrolytic enzyme or of microorganism containing or producing hydrolytic enzymes in these compositions. The invention also pertains to methods for improving the biological effects of the rosemary extracts and for administering such compositions to a human or animal subject for improving the skin, coat, hair or health of the subject.

Claims (5)

1. A topical composition comprising rosmarinic acid in combination with hydrolysis effective amounts of a probiotic microorganism containing or producing a hydrolytic enzyme of an esterase so that the rosmarinic acid is hydrolyzed to provide caffeic acid and 3,4-dihydroxy phenyllactic acid in the composition in amounts sufficient to provide an inhibitory effect on the expression of matrix metalloproteinase-1 compared to non-hydrolysed rosmarinic acid containing compositions when the composition is applied to skin; wherein the composition is in the form of an aqueous, aqueous-alcoholic or oily solution, a dispersion of the solution, lotion, or serum type, an emulsion that has a liquid or semi-liquid consistency, obtained by dispersion of a fatty phase in an aqueous phase (O/W) or vice-versa (W/O), or a suspension or emulsion that has a soft, semi-solid or solid consistency, microcapsules, microparticles or vesicular dispersions, wherein the topical composition is useful for treating skin damage.

2. The composition according to claim 1 , wherein the probiotic microorganism is selected from the group consisting of bacteria, yeasts and fungi.

3. The composition according to claim 2 , wherein the probiotic microorganism is selected from the group consisting of Lactobacillus johnsonii (CNCM I-1225), Bifidobacterium longum (ATCC BAA-999), Bifidobacterium lactis (CNCM I-3446) and mixtures thereof.

4. The composition according to claim 1 , which further comprises ingredients selected from the group consisting of carbohydrates, proteins, lipids, vitamins, prebiotics, minerals, plant extracts, fibres, excipients, and flavourings.

5. The composition according to claim 1 , wherein the probiotic microorganism is Lactobacillus johnsonii (CNCM I-1225).

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →